Western Europe remains at the forefront of evidence-based harm reduction and treatment interventions. The majority of the countries in the region have adopted a health-based strategy towards drug use (including decriminalisation of possession for personal use), and are moving towards more proportionate sentences for drug offences.
According to the study, key interventions to reduce infections are needle and syringe programmes which minimise the use of contaminated equipment, and opioid substitution therapy including methadone, buprenorphine and naloxone.
The report argues that to face mortality rates among people who use drugs in the UK the use of drug consumption rooms is imperative, especially in light of the rise of synthetic opioids like fentanyl and carfentanil.
The Commission will also organise a 12-week online public consultation (accessible via the Commission's public consultations page) allowing the wider public to share views and inputs. It will run in Spring 2018.
The EMCDDA publishes a report providing an update on infectious diseases related to injecting drug use in Europe. It covers both the EMCDDA Drug-related infectious diseases indicator, which collects data on the situation, and the responses in the area.